1 / 5

Nuclear Medicine Market

The market of radiopharmaceuticals is dominated by diagnostic radioisotopes, comprising of SPECT and PET radioisotopes. The lions share of the SPECT market is taken up by Tc-99m, whereas the PET market is dominated by F-18FDG isotope. Furthermore, the PET market will witness a double digit growth during the forecast period. The therapeutic segment contributes only 10% to the global radiopharmaceuticals market and I-131 has been considered as the gold standard for various oncology treatments in a combined therapy. Global nuclear medicines market is majorly driven by the increasing adoption of PET and SPECT scanners, and rising awareness for radiopharmaceuticals, whereas short half life of isotopes and stringent regulations are the factors that are hindering the growth of radiopharmaceuticals worldwide.

guest98911
Télécharger la présentation

Nuclear Medicine Market

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Nuclear Medicine Market & Radiopharmaceuticals 

  2. Summary The market of radiopharmaceuticals is dominated by diagnostic radioisotopes, comprising of SPECT and PET radioisotopes. The lions share of the SPECT market is taken up by Tc-99m, whereas the PET market is dominated by F-18FDG isotope. Furthermore, the PET market will witness a double digit growth during the forecast period. The therapeutic segment contributes only 10% to the global radiopharmaceuticals market and I-131 has been considered as the gold standard for various oncology treatments in a combined therapy. Global nuclear medicines market is majorly driven by the increasing adoption of PET and SPECT scanners, and rising awareness for radiopharmaceuticals, whereas short half life of isotopes and stringent regulations are the factors that are hindering the growth of radiopharmaceuticals worldwide.

  3. Custom Research/ Customization - Nuclear Medicine Market RADIOPHARMACEUTICALS MARKET1. PET and SPECT procedural volume (No. of procedures) at regional level and by IsotopeEstimation of diagnostic and therapeutic procedures in North America, Europe, Asia, and RoW for 2010, 2011, 2012, and the forecast for 2017Estimation of SPECT, PET, Beta emitters and Brachytherapy procedures in North America, Europe, Asia, and RoW for 2010, 2011, 2012, and forecast for 2017Radiopharmaceutical market for South Africa & Brazil To know more information about this report click here – http://www.jsbmarketresearch.com/healthcare-medical/r-Nuclear-Medicine-Market-Radiopharmaceuticals-SPECTPET-Radioisotopes-63721

  4. About JSB Market Research • Jsbmarketresearch.com is an online repository of an extensive collection of market research reports available online. This online portal contains high-quality reports with well-researched and high-quality content on a wide range of industries. These market research reports help us give a detailed insight into new opportunities in the industry, prevailing market trends, competitor analysis and future prospects. • JSB’s reports are developed by the domain experts and publishers under a closely observed surveillance of industry specialists. Therefore, the researched data is well researched, well- organized and matching up to the best standards in the industry. Also JSB’s database consists of detailed insights of the leading players in the global market, products and trends.

  5. Contact Us Support & General Inquiries Mail :support@jsbmarketresearch.com1-800-986-4312 Billing Support Mail :billing@jsbmarketresearch.com+91 22 412 366 50 Websitehttp://www.jsbmarketresearch.com

More Related